A multi-omics analysis of transformed nodal marginal zone lymphoma
Background:The mechanisms underlying transformation of nodal marginal zone lymphoma (NMZL) into diffuse large B-cell lymphoma (DLBCL) remain unclear.Patients and methods: We applied a multi-omics approach to analyze genomic and transcriptomic changes in 17 NMZL and 15 transformed NMZL (tNMZL), using whole genome sequencing, targeted sequencing, and gene expression profiling.Results: We included 15 nodal DLBCL cases as controls.The median fraction of genome altered was significantly higher in tNMZL compared with NMZL [0.23 (range 0.14-0.67),versus 0.11 (range 3.1 10 -4 -0.34), P < 0.01].The median number of mutations was not different, with 3 (range 0-10) in NMZL, compared with 6.5 (range 2-16) (P = 0.10) in tNMZL.In contrast, the median number of pathogenic mutations in nodal DLBCL (8.5, range 5-17) was significantly higher compared with NMZL (P < 0.01) and tNMZL (P = 0.04).The most frequently mutated genes in tNMZL included B2M (30%) and MEF2B (30%).Protein expression of BCL6, a downstream target of MEF2B, was observed more frequently in tNMZL (73%), compared with NMZL (6%) (P < 0.01).Overall, six genes were differentially expressed between NMZL and tNMZL. Conclusion:In conclusion, our study indicates that transformation of NMZL is characterized by a slight increase in genomic complexity and a gain of BCL6 expression.
Authors
- Nick Veltmaat (ORCID: https://orcid.org/0000-0003-2635-3528)
- Anke van den Berg (ORCID: https://orcid.org/0000-0002-8894-2638)
- Fleur A. de Groot (ORCID: https://orcid.org/0000-0001-9940-2891)
- Marcel Nijland (ORCID: https://orcid.org/0000-0002-2740-2873)
- Johanna Bult (ORCID: https://orcid.org/0009-0000-6090-4448)
- Diana Al-Sarayfi (ORCID: https://orcid.org/0000-0003-0496-6403)
- Wouter J. Plattel (ORCID: https://orcid.org/0000-0001-9828-9460)
- Joost S.P. Vermaat (ORCID: https://orcid.org/0000-0002-1628-6256)
- Angelika Seitz (ORCID: https://orcid.org/0000-0002-6380-5012)
- Joost L. Kluiver (ORCID: https://orcid.org/0000-0001-7650-2937)
- Arjan Diepstra (ORCID: https://orcid.org/0000-0001-9239-1050)
- Yujie Zhong (ORCID: https://orcid.org/0009-0003-6481-3916)
- Ruben A. L. de Groen (ORCID: https://orcid.org/0000-0002-2998-2066)
- S. Rosati (ORCID: https://orcid.org/0000-0003-0838-5980)
- Mirjam F. Mastik
- Erjan Hilbrands
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Leiden University Medical Center (NL)
Publication Details
- Journal
- ESMO rare cancers.
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.esmorc.2025.100040
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00